90.9 WBUR - Boston's NPR news station
Top Stories:
PLEDGE NOW
Patenting Human Genes
Patient samples are loaded into a machine for testing at Myriad Genetics in Salt Lake City. (AP)

Patient samples are loaded into a machine for testing at Myriad Genetics in Salt Lake City. (AP)

Post your comments below

The human genetic code is a kind of miracle. It’s also a recipe for life.

It’s also widely seen as a giant business opportunity. Corporations, drug companies, are rapidly staking claims.

Twenty percent of the human genome has already been patented — sewn up for research and profit in the emerging field of genetic medicine. And it’s fiercely defended.

Gene patenting is controversial, but it’s the law of the land. A lawsuit headed to court right now would change that.

This hour, On Point: Playing God, pushing research, and patenting the human genome.

Guests:

Joining us from Salt Lake City is Tom Harvey, business reporter at The Salt Lake Tribune, where he’s covering the Myriad Genetics case.

Joining us from New York is Chris Hansen, Senior National Staff Counsel at the American Civil Liberties Union. He is lead attorney in the gene patenting lawsuit that pits the ACLU against the Salt Lake City firm Myriad Genetics and the US Patent and Trademark Office. You can read the ACLU’s complaint here (pdf).

From Washington we’re joined by Hans Sauer, Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization, known as BIO. Its membership includes more than 1,200 biotechnology companies and is aligned with Myriad Genetics in defense of gene patenting.

And from New York we’re joined by Wendy Chung, M.D., Ph.D., director of clinical genetics at Columbia University and a plaintiff in the ACLU v. Myriad Genetics case.

Please follow our community rules when engaging in comment discussion on this site.
ONPOINT
TODAY
Oct 31, 2014
Nurse Kaci Hickox, right, and her boyfriend, Ted Wilbur are followed by a Maine State Trooper as they ride bikes on a trail near her home in Fort Kent, Maine, Thursday, Oct. 30, 2014.  (AP)

Quarantines and Ebola. An exploding rocket. Apple’s CEO comes out. Hawaiian lava flows. Midterms in the home stretch. Our weekly news roundtable goes behind the headlines.

Oct 31, 2014
Doc Sportello (Joaquin Phoenix) and Sauncho Smilax (Beninico del Toro) share a drink in a scene from the upcoming Paul Thomas Anderson film, "Inherent Vice," an adaptation of the Thomas Pynchon novel of the same name. (Courtesy Warner Bros. Entertainment)

from “Interstellar” to “Into the Woods.” The biggest and best movies of the fall and holiday seasons. What to see, what to skip.

RECENT
SHOWS
Oct 30, 2014
Soylent is a new meal-replacement substance meant to offer a complete nutritional alternative to traditional food. (Courtesy Soylent)

Soylent is a grey smoothie the consistency of pancake batter that claims it can replace all your food. On a crowded planet, is this the future of food? Plus: what does the Antares rocket crash mean for private space travel?

 
Oct 30, 2014
Realtor Helen Hertz stands in front of one of her listings in Cleveland Heights, Ohio Friday, Oct. 24, 2014. Hertz, a real estate agent for more than three decades, has seen firsthand what has happened to the market in the wake of the recession and foreclosure crisis. (AP)

Home ownership rates are at a 20-year low. Millennials and more aren’t buying. We’ll look at what American’s think now about owning a home.

On Point Blog
On Point Blog
A Bit More On The History Of Quarantine
Thursday, Oct 30, 2014

So this whole quarantine thing — why to do it, when to do it, and when to just say no.

More »
Comment
 
The Explicast, Episode Two: Why Is Election Day On A Tuesday?
Friday, Oct 24, 2014

The Explicast is back for another round. This time, we’re looking at Election Day, and why we all keep voting on a random Tuesday in early November.

More »
2 Comments
 
Our Week In The Web: October 24, 2014
Friday, Oct 24, 2014

On comments, comment sections, and ROY G BIV.

More »
Comment